Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02099734 · ClinicalTrials.gov registry record
Germ Cell Tumor and Testicular Tumor DNA Registry
A clinical trial of Germ Cell Tumor and Testicular Tumor, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 8
- Study locations
NCT02099734: Recruiting study of Germ Cell Tumor and Testicular Tumor, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02099734 is a study of Germ Cell Tumor and Testicular Tumor that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 1,000 participants, above the 295-participant average among 19 other Germ Cell Tumor trials with a reported enrollment target (239% higher). The trial reports 8 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02099734, a study of Germ Cell Tumor and Testicular Tumor, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 8
- Study locations
Study Summary
This study is being done to create a registry to help us learn more about germ cell tumors (GCT) and other testicular tumors. The registry will include people with these tumors and also relatives and unrelated people without these tumors. This study will help us learn more about the prevention, diagnosis, treatment and outcome of these tumors. Studying relatives of patients and people unrelated to patients with GCT and other testicular tumors will help us understand why some people get these tumors and why some people don't.
Primary Outcome
We will collect clinical data including diagnosis date, pathology, family history, and risk factors in patients with GCT-TT.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaires
- OTHER sample of blood or saliva
Study Locations (8)
New York
- Cold Springs Harbor Laboratory (Specimen Analysis) - Cold Spring Harbor
- Memorial Sloan Kettering Commack - Commack
- Memorial Sloan Kettering Westchester - Harrison
- Memorial Sloan Kettering Cancer Center - New York
- Memorial Sloan Kettering Nassau - Uniondale
New Jersey
- Memorial Sloan Kettering Basking Ridge - Basking Ridge
- Memorial Sloan Kettering Monmouth - Middletown
- Memorial Sloan Kettering Bergen - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2014-01 |
| Est. Completion | 2028-01 |
What NCT02099734 shows while recruiting
NCT02099734 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 295-participant average among 19 other Germ Cell Tumor trials with a reported enrollment target (239% higher).
The record links to 2 conditions, with Germ Cell Tumor appearing as the primary indexed condition, and to 2 interventions - of which Questionnaires is the first listed.
NCT02099734 lists 8 locations in 2 states (New York, New Jersey).
Frequently Asked Questions
What is clinical trial NCT02099734 about?
NCT02099734 is a clinical study titled "Germ Cell Tumor and Testicular Tumor DNA Registry". This study is being done to create a registry to help us learn more about germ cell tumors (GCT) and other testicular tumors. The registry will include people with these tumors and also relatives and unrelated people without these tumors. This study will help us learn more about the prevention, diag...
What is the current status of trial NCT02099734?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2014-01. Estimated completion is 2028-01.
What conditions does trial NCT02099734 study?
This clinical trial studies the following conditions: Germ Cell Tumor, Testicular Tumor.
What interventions are being tested in trial NCT02099734?
The interventions under investigation include: Questionnaires (BEHAVIORAL), sample of blood or saliva (OTHER).
Who is sponsoring clinical trial NCT02099734?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02099734 being conducted?
This trial has 8 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Germ Cell Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02099734's enrollment target sits among peer trials
1,000 3rd of 19 higher than 17 of 19 other Germ Cell Tumor trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Germ Cell Tumor trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
RECRUITING · Phase 1
-
Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
RECRUITING · Phase 1
-
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
RECRUITING · Phase 3
-
Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
RECRUITING · Phase 3
-
Maintenance Oral Etoposide or Observation Following High-dose Chemo for GCT
RECRUITING · Phase 2
-
A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia